NeurologyLive® Top Expert Interviews: September 2022
Expert clinicians offer their perspectives on developmental milestones for children, the NMSOD patient perspective, effective treatments for insomnia, ALS, diabetic and inflammatory neuropathies, and lecanemab in early Alzheimer disease.
The NeurologyLive® team has been as busy as ever collecting expert insight on the latest clinical news and research updates in neurology over the course of the past month by conducting several interviews across various topics of neurological care.
Among these included conversations about the changes in practice and developmental milestones for children, the patient perspective on neuromyelitis optica spectrum disorder (NMSOD), the state of insomnia and the effective treatment strategies, the role of human endogenous retroviruses in amyotrophic lateral sclerosis (ALS), the changing treatment of diabetic and inflammatory neuropathies, and lecanemab’s effect in early Alzheimer disease (AD).
Click through the slides to see and read more from each expert’s exclusive conversation with NeurologyLive® in September 2022.
To hear more insight from experts in the clinical care of patients and leading researchers in neurology, check out more of NeurologyLive®'s videos.
